OptimizeRX
Mandi Boehly Schmauch has a diverse and extensive work experience in sales and management roles. Mandi Boehly currently serves as the VP of Sales at OptimizeRx. Prior to this, they worked at Detect as the Sales Director, where they were responsible for generating revenue and selling molecular covid tests to various enterprise customers globally. Mandi Boehly successfully sold to Fortune 500 companies, state governments, global corporations, universities, professional sports teams, government contractors, healthcare insurance providers, consultants, and professional employer organizations.
Before their role at Detect, Mandi worked at Novo Nordisk for several years, holding various positions such as Business Manager, Support Manager, Field Sales Trainer, and Senior Sales Specialist. In these roles, they demonstrated exceptional leadership and expertise in executing sales strategies, managing teams, conducting sales training, and driving market growth.
Prior to Novo Nordisk, Mandi served as an Account Executive at Myriad Genetics, where they managed a $12MM territory for Genetic Testing in Hereditary Breast and Ovarian Cancer and Colon Cancer. Mandi Boehly was also recognized as a national award winner for sales.
Earlier in their career, Mandi worked at Boston Scientific as an Account Manager for Latitude Remote Technology and as a Clinical Sales Representative. Mandi Boehly also gained experience as an Account Manager at Imaging Heart and as a Senior Sales Representative at Merck.
Overall, Mandi Boehly Schmauch has a successful track record in sales and management roles, consistently achieving sales targets, driving revenue growth, and building strong relationships with diverse clients and stakeholders.
Mandi Boehly Schmauch completed their Bachelor of Arts in Biology from William & Mary in 1998. Prior to that, they attended Holton-Arms School.
This person is not in any offices
OptimizeRX
1 followers
OptimizeRx® (OPRX) provides unique physician and consumer platforms and strategies to help patients better afford and adhere to their treatment regimens while offering pharmaceutical and healthcare companies more effective ways to deliver relevant information and services to healthcare providers and their patients right at the point of care.